Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Antel

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Brain Pathology (Zurich, Switzerland)|January 10, 2020
Extensive subpial cortical demyelination is specific to multiple sclerosisAndreas Junker, Jadwiga Wozniak, David Voigt, et al.
Clinical Immunology (Orlando, Fla.)|July 6, 2010
Reconstitution of circulating lymphocyte counts in FTY720-treated MS patientsTrina A Johnson, Igor Shames, Mark Keezer, et al.
Journal of Neuropathology and Experimental Neurology|August 20, 2010
Response of human oligodendrocyte progenitors to growth factors and axon signalsQiao Ling Cui, Gabriela Fragoso, Veronique E Miron, et al.
Stem Cells and Development|November 30, 2011
Human fetal oligodendrocyte progenitor cells from different gestational stages exhibit substantially different potential to myelinateQiao-Ling Cui, Lia D'Abate, Jun Fang, et al.
Scientific Reports|January 17, 2020
Pre-treatment T-cell subsets associate with fingolimod treatment responsiveness in multiple sclerosisMahtab Ghadiri, Ayman Rezk, Rui Li, et al.
Neurology|January 24, 2014
Naive CD4 T-cell activation identifies MS patients having rapid transition to progressive MSEvelyn Zastepa, Leslie Fitz-Gerald, Michael Hallett, et al.
Journal of Neurology|September 5, 2015
Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosisXavier Montalban, Giancarlo Comi, Jack Antel, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 6, 2017
Dimethyl fumarate-induced lymphopenia in MS due to differential T-cell subset apoptosisMahtab Ghadiri, Ayman Rezk, Rui Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 17, 2019
Correction: Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple SclerosisRui Li, Ayman Rezk, Mahtab Ghadiri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 16, 2016
Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple SclerosisRui Li, Ayman Rezk, Mathab Ghadiri, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Brain Pathology (Zurich, Switzerland)|January 10, 2020
Extensive subpial cortical demyelination is specific to multiple sclerosisAndreas Junker, Jadwiga Wozniak, David Voigt, et al.
Clinical Immunology (Orlando, Fla.)|July 6, 2010
Reconstitution of circulating lymphocyte counts in FTY720-treated MS patientsTrina A Johnson, Igor Shames, Mark Keezer, et al.
Journal of Neuropathology and Experimental Neurology|August 20, 2010
Response of human oligodendrocyte progenitors to growth factors and axon signalsQiao Ling Cui, Gabriela Fragoso, Veronique E Miron, et al.
Stem Cells and Development|November 30, 2011
Human fetal oligodendrocyte progenitor cells from different gestational stages exhibit substantially different potential to myelinateQiao-Ling Cui, Lia D'Abate, Jun Fang, et al.
Scientific Reports|January 17, 2020
Pre-treatment T-cell subsets associate with fingolimod treatment responsiveness in multiple sclerosisMahtab Ghadiri, Ayman Rezk, Rui Li, et al.
Neurology|January 24, 2014
Naive CD4 T-cell activation identifies MS patients having rapid transition to progressive MSEvelyn Zastepa, Leslie Fitz-Gerald, Michael Hallett, et al.
Journal of Neurology|September 5, 2015
Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosisXavier Montalban, Giancarlo Comi, Jack Antel, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 6, 2017
Dimethyl fumarate-induced lymphopenia in MS due to differential T-cell subset apoptosisMahtab Ghadiri, Ayman Rezk, Rui Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 17, 2019
Correction: Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple SclerosisRui Li, Ayman Rezk, Mahtab Ghadiri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 16, 2016
Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple SclerosisRui Li, Ayman Rezk, Mathab Ghadiri, et al.
Pageof 10